1. Odenwald MA, Paul S. Viral hepatitis: Past, present, and future. World J Gastroenterol. 2022; 28: 1405-1429.
2. Umemura T, tanaka E, ostapowicz G. Investigation on of SEN virüs infection in patients with cryptogenic acute and chronic non-A-E hepatitis.J Infect Dis. 2003;188:1545-1552
3. Pessoa MG, terrault NA, DetmerJ et al. Quantation of hepatitis G and C viruses in the liver: evidence that hepatitis G virüs is not hepatotropic. Hepatology 1998;27:887.
4. Curry MP, Chopra S. Acute Viral Hepatitis. In: Mandell GL, Bennett JE, Dolin R (eds). Principles and Practice of Infectious Diseases. Philadelphia: Elsevier Churchill Livingstone, 2010:1577-
1592.
5. Nelson R. Hepatitis A outbreak in the USA. Lancet Infect Dis. 2018; 18: 33-34.
6. Karacaer Z, Tosun S, Batırel A et al., Changes in acute viral hepatitis epidemiology in the Turkish adult population: A multicenter study. Turk J Gastroenterol. 2018; 29: 177-182.
7. https://www.who.int/news-room/fact-sheets/detail/hepatitis-b (Acsessed 12 March 2024)
8. Ay P, Torunoglu MA, Com S, et al. Trends of hepatitis B notification rates in Turkey, 1990 to 2012. Euro Surveill. 2013; 18: 1–7.
9. Miao Z, Zhang S, Ou X, et al. Estimating the Global Prevalence, Disease Progression, and Clinical Outcome of Hepatitis Delta Virus Infection. J Infect Dis 2020; 221:1677.
10. Kwong S, Meyerson C, Zheng W, et al. Acute hepatitis and acute liver failure: Pathologic diagnosis and differential diagnosis. Semin Diagn Pathol. 2019; 36: 404-414.
11. Tozun N, Ozdogan O, Cakaloglu Y, et al. Seroprevalence of hepatitis B and C virüs infections and risk factors in Turkey: a field work TURHEP study. Clin Microbiol Infect 2015; 21: 1020-1026
12. World Health Organization. Hepatitis E Fact sheet (updated July 2017). http://www.who.int/mediacentre/factsheets/fs280/en/ (Accessed on March 20, 2024).
13. Kwong S, Meyerson C, Zheng W, et al. Acute hepatitis and acute liver failure: Pathologic diagnosis and differential diagnosis. Semin Diagn Pathol. 2019; 36: 404-414.
14. Kwo PY, Cohen SM, Lim JK. ACG Clinical Guideline: Evaluation of Abnormal Liver Chemistries. Am J Gastroenterol. 2017; 112: 18-35.
15. Shin EC, Jeong SH. Natural history, clinical manifestations, and pathogenesis of hepatitis A. Cold Spring Harb Perspect Med. 2018; 8: a031708.
16. Cuthbert JA. Hepatitis A: old and new. Clin Microbiol Rev 2001; 14: 38.
17. Inman RD, Hodge M, Johnston ME, et al. Arthritis, vasculitis, and cryoglobulinemia associated with relapsing hepatitis A virus infection. Ann Intern Med 1986; 105: 700.
18. Langan RC, Goodbred AJ. Hepatitis A. Am Fam Physician. 2021; 104: 368-374.
19. Lanini S, Ustianowski A, Pisapia R, et al. Viral Hepatitis: Etiology, Epidemiology, Transmission, Diagnostics, Treatment, and Prevention. Infect Dis Clin North Am. 2019; 33: 1045-1062.
20. Nguyen D.H, Ludgate L, Hu J: Hepatitis B virus-cell interactions and pathogenesis. J Cell Physiol 2008; 216: 289-294.
21. Mikulska M, Lanini S, Gudiol C, et al: ESCMID Study Group for Infections in Compromised Hosts (ESGICH) Consensus Document on the safety of targeted and biological therapies: an
infectious diseases perspective (Agents targeting lymphoid cells surface antigens: CD19, CD20 and CD52). Clin Microbiol Infect 2018; 24: 71-82.
22. Trépo C, Chan HL, Lok A. Hepatitis B virus infection. Lancet. 2014; 384: 2053-63.
23. Demirtürk N, Köse A, Ural O, et al. Management of chronic hepatitis B infection: A consensus report of the Study Group for Viral Hepatitis of the Turkish Society of Clinical Microbiology
and Infectious Diseases-2023 Update. Klimik 2023;36:1-22.
24. di Filippo Villa D, Navas MC. Vertical Transmission of Hepatitis B Virus-An Update. Microorganisms. 2023;11: 1140.
25. Aslam A, Campoverde Reyes KJ, Malladi VR, et al. Management of chronic hepatitis B during pregnancy. Gastroenterol Rep (Oxf). 2018;6: 257-262.
26. Furuncuoglu Y, Bolukbas F, Bolukbas C, et al. Changes İn The Prevalence Of HBV İnfection İn Pregnant Women İn Turkey Between 1995 And 2015: A 20-Year Evaluation. Postgrad Med J,
2016; 92: 510-513.
27. Oh IS, Park SH. Immune-mediated Liver Injury in Hepatitis B Virus Infection. Immune Netw. 2015; 15: 191–198.
28. Guillevin L, Lhote F, Cohen P, et al. Polyarteritis nodosa related to hepatitis B virus. A prospective study with long-term observation of 41 patients. Medicine (Baltimore) 1995; 74: 238.
29. Lai KN, Lai FM, Chan KW, et al. The clinico-pathologic features of hepatitis B virus-associated glomerulonephritis. Q J Med 1987; 63: 323.
30. Bernal W, Auzinger G, Dhawan A, Wendon J. Acute liver failure. Lancet 2010; 376: 190.
31. Hoofnagle JH, DiBisceglie AM. Serologic diagnosis of acute and chronic viral hepatitis. Semin Liver Dis 1991; 11: 73-83.
32. Terrault NA, Lok ASF, McMahon BJ, et al. Uptodate on Prevention, diagnosis, and treatment of choronic hepatitis B:AASLD 2018 hepatitis B guidance. Hepatology 2018; 64: 1560.
33. Ichai P, Samuel D. Management of Fulminant Hepatitis B. Curr Infect Dis Rep. 2019; 21: 25.
34. Schillie S, Vellozzi C, Reingold A,et al. Prevention of Hepatitis B virüs Infection in the United States: Recommendations of the Advisory Commitee on immunization Practices MMWR Re-
comm Rep. 2018; 67: 1-31.
35. Schillie S,Murphy TV, Sawyer M, et al. Centers for Disease Control and Prevention (CDC) guidance for evaluating health care personnel for hepatitis B virüs protection and for administering
postexposure management. MMWR Recomm Rep. 2013; 62: 1-19.
36. Chigbu DI, Loonawat R, Sehgal M, Patel D, Jain P. Hepatitis C Virus Infection: Host⁻Virus Interaction and Mechanisms of Viral Persistence. Cells. 2019; 8: 376.
37. Degenhardt L, Peacock A, Colledge S, et al. Lancet Glob Health 2017; 5: e1192.
38. Mauser-Bunschoten EP, Bresters D, van Drimmelen AA, et al. Hepatitis C infection and viremia in Dutch hemophilia patients. J Med Virol 1995; 45: 241.
39. Puro V, Petrosillo N, Ippólito G, Italian study Group on occupational risk of HIV and other bloodborne infections. Risk of hepatitis C seroconversion after occupational exposures in health-
care workers. Am J Infect Control 1995; 23: 273-7
40. Loomba R, Rivera MM, McBurney R, et al. The natural history of acute hepatitis C: clinical presentation, laboratory findings and treatment outcomes. Aliment Pharmacol Ther 2011; 33: 559.
41. Guss D, Sherigar J, Rosen P, Mohanty SR. Diagnosis and Management of Hepatitis C Infection in Primary Care Settings. J Gen Intern Med. 2018; 33: 551-557.
42. Colin C, Lanoir D, Touzet S, Meyaud-Kraemer L, Bailly F, Trepo C; HEPATITIS Group. Sensitivity and specificity of third-generation hepatitis C virus antibody detection assays: an analysis
of the literature. J Viral Hepat. 2001; 8: 87-95.
43. Bilgehan A, Gürbüz Y, Çetinkaya RA, et al. Management of chronic hepatitis C virus infection: A consensus report of the Study Group for Viral Hepatitis of the Turkish Society of Clinical
Microbiology and Infectious Diseases-2023 Update. Klimik 2023;36:43-75.
44. European Association for the Study of the Liver. EASL Clinical Practice Guidelines on hepatitis delta virus. J Hepatol. 2023;79:433-460.
45. Sellier PO, Maylin S, Brichler S, et al. Hepatitis B Virus-Hepatitis D Virus mother-to-child co-transmission: a retrospective study in a developed country. Liver Int. 2018; 38: 611–618.
46. Negro F, Lok AS. Hepatitis D: A Review. JAMA 2023; 330: 2376–2387.
47. Price J. An update on hepatitis B, D, and E viruses. Top Antivir Med. 2014; 21: 157-63.
48. Buti M, Esteban R, Jardí R, et al. Serological diagnosis of acute delta hepatitis. J Med Virol 1986; 18: 81.
49. Aslan AT, Balaban HY. Hepatitis E virus: Epidemiology, diagnosis, clinical manifestations, and treatment. World J Gastroenterol. 2020; 26: 5543-5560.
50. İveiro-Barciela M, Sauleda S, Quer J, et al. Red blood cell transfusion-transmitted acute hepatitis E in an immunocompetent subject in Europe: a case report. Transfusion 2017; 57: 244–247.
51. Stoszek SK, Abdel-Hamid M, Saleh DA, et al. High prevalence of hepatitis E antibodies in pregnant Egyptian women. Trans R Soc Trop Med Hyg 2006; 100: 95.
52. Shrestha MP, Scott RM, Joshi DM, et al. Safety and efficacy of a recombinant hepatitis E vaccine. N Engl J Med 2007; 356: 895.
53. Khuroo MS, Dar MY. Hepatitis E: evidence for person-to-person transmission and inability of low dose immune serum globulin from an Indian source to prevent it. Indian J Gastroenterol
1992; 11: 113.